<DOC>
	<DOCNO>NCT02404753</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy laparoscopic distal D2 gastrectomy ( LDG ) compare open surgery ( ODG ) resectable gastric cancer , determine whether LDG test arm future Phase III trial evaluate non-inferiority overall survival compare ODG patient receive neoadjuvant chemotherapy .</brief_summary>
	<brief_title>A Comparison Laparoscopic With Open Distal Gastrectomy Advanced Gastric Cancer After Neoadjuvant Chemotherapy</brief_title>
	<detailed_description>The study open-label , control , randomize Phase II clinical trial . The protocol approve Ethics Committee Beijing Cancer Hospital . The primary endpoint 3-year progression-free survival ( PFS ) rate . The secondary endpoint overall survival , surgical morbidity mortality .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Histologically proven adenocarcinoma stomach . Clinical cT2N+M0 , cT34a/N+M0 disease , confirm upper gastrointestinal endoscopy abdominal compute tomography ( CT ) laparoscopy . The T N stage determine method Habermann et al . The gastric tumor locate middle low third stomach , macroscopically resectable distal gastrectomy D2 lymph node dissection , R0 R1 resection achieve . No bulky lymph node metastasis detect abdominal CT. No pleural effusion , ascites exceed pelvis metastasis peritoneum , liver distant organ confirm abdominal pelvic CT. No clinically apparent distant metastasis . Karnofsky performance status ≥70 % . Sufficient oral intake . No previous treatment chemotherapy radiation therapy tumor . No previous surgery present disease . Sufficient organ function , evaluate laboratory test 7 day date anticancer drug give . When patient recover myelosuppression , revise criterion show parenthesis . White blood cell count≥3000/mm3 ( 2000/mm3 ) Platelet count≥10.0*104/mm3 ( 5.0*104/mm3 ) Aspartate aminotransferase≤100 IU/l Alanine aminotransferase≤100 IU/l Total bilirubin≤2.0 mg/dl Serum creatinine≤1.5 mg/dl No need emergency surgery due bleed perforation primary tumor . No mechanical obstruction . Written informed consent . Past history upper abdominal surgery . Past history surgery gastrointestinal tract . Body mass index exceed 30 kg/m2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Locally advanced gastric cancer</keyword>
	<keyword>Laparoscopic distal D2 gastrectomy</keyword>
	<keyword>Neoadjuvant chemotherapy</keyword>
</DOC>